EGFR and non-small cell lung carcinoma: The Epidermal Growth Factor Receptor (EGFR)-activating mutations are the most common molecular aberrations in NSCLC, being present in 15% of the Caucasian population and up to 50% of the Asian population with advanced NSCLC [1,2].